Xiaoyi Zhang Selected Research

imidazo(1,2-a)quinoxaline-2-carboxylic acid

1/2018	Design and synthesis of nanoscaled IQCA-TAVV as a delivery system capable of antiplatelet activation, targeting arterial thrombus and releasing IQCA.
2/2017	IQCA-TASS: a nano-scaled P-selectin inhibitor capable of targeting thrombus and releasing IQCA/TARGD(S)S in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiaoyi Zhang Research Topics

Disease

48	Neoplasms (Cancer) 11/2022 - 03/2010
12	Thrombosis (Thrombus) 01/2020 - 01/2011
10	Inflammation (Inflammations) 01/2022 - 02/2013
7	Neoplasm Metastasis (Metastasis) 08/2022 - 02/2015
6	Fibrosis (Cirrhosis) 01/2022 - 01/2014
6	Hypoxia (Hypoxemia) 01/2022 - 09/2016
5	Type 2 Diabetes Mellitus (MODY) 01/2022 - 05/2019
5	Breast Neoplasms (Breast Cancer) 01/2021 - 03/2010
4	Glioma (Gliomas) 08/2022 - 01/2020
4	Carcinogenesis 01/2022 - 02/2015
4	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 12/2019
3	Insulin Resistance 12/2022 - 01/2019
3	Pancreatitis 01/2021 - 01/2017
3	Brain Neoplasms (Brain Tumor) 11/2020 - 01/2020
3	Venous Thrombosis (Deep-Vein Thrombosis) 01/2020 - 01/2018
3	Hypertension (High Blood Pressure) 01/2019 - 01/2018
2	Postoperative Nausea and Vomiting (PONV) 12/2022 - 12/2021
2	Carcinoma (Carcinomatosis) 08/2022 - 03/2010
2	Fatigue 06/2022 - 11/2021
2	Premature Ejaculation 06/2022 - 11/2021
2	Ankylosing Spondylitis 05/2022 - 11/2021
2	Body Weight (Weight, Body) 04/2022 - 12/2021
2	Non-alcoholic Fatty Liver Disease 01/2022 - 05/2019
2	Hemorrhage 12/2021 - 01/2018
2	Peripheral Nervous System Diseases (PNS Diseases) 11/2021 - 10/2020
2	Cardiotoxicity 11/2021 - 01/2019
2	Chronic Pain 11/2021 - 10/2010
2	Cardiomegaly (Heart Hypertrophy) 11/2020 - 01/2018
2	Edema (Dropsy) 01/2020 - 09/2017
2	Poisoning 02/2019 - 09/2012
2	Renal Cell Carcinoma (Grawitz Tumor) 08/2018 - 02/2015
2	Cardiovascular Diseases (Cardiovascular Disease) 05/2018 - 01/2018
2	Myocardial Infarction 01/2018 - 06/2015
2	Lymphoma (Lymphomas) 01/2016 - 02/2015
2	Melanoma (Melanoma, Malignant) 05/2015 - 08/2012
2	Prostatic Neoplasms (Prostate Cancer) 11/2012 - 03/2010
2	Osteoporosis 05/2009 - 04/2009
1	Flatulence 12/2022
1	Papillary Thyroid Cancer 08/2022
1	Asthma (Bronchial Asthma) 06/2022

Drug/Important Bio-Agent (IBA)

11	Proteins (Proteins, Gene)FDA Link 11/2022 - 12/2014
10	Biomarkers (Surrogate Marker)IBA 08/2022 - 01/2018
8	AcidsIBA 01/2020 - 10/2010
7	P-SelectinIBA 01/2020 - 01/2017
5	Glucose (Dextrose)FDA LinkGeneric 12/2022 - 01/2013
5	MicroRNAs (MicroRNA)IBA 08/2022 - 01/2018
5	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 03/2010
4	Messenger RNA (mRNA)IBA 08/2022 - 12/2014
4	Biological ProductsIBA 01/2022 - 12/2011
4	Pharmaceutical PreparationsIBA 01/2022 - 08/2012
4	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2020 - 03/2010
4	Interleukin-8 (Interleukin 8)IBA 01/2020 - 01/2017
3	Silk FDA Link 10/2022 - 04/2021
3	HydrogelsIBA 01/2022 - 01/2018
3	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2022 - 01/2020
3	7- ethyl- 7- hydroxy- 10H- 1,3- Dioxolo(4,5- g)pyrano(3',4':6,7)indolizino(1,2- b)quinoline- 8,11(7H,12H)- dioneIBA 09/2020 - 12/2019
3	Antineoplastic Agents (Antineoplastics)IBA 01/2020 - 01/2017
3	Matrix Metalloproteinases (MMPs)IBA 08/2018 - 09/2017
3	ChemokinesIBA 01/2016 - 12/2014
2	Metal-Organic FrameworksIBA 08/2022 - 11/2020
2	Indicators and Reagents (Reagents)IBA 06/2022 - 01/2017
2	Phosphorus (Red Phosphorus)IBA 04/2022 - 12/2021
2	LipidsIBA 01/2022 - 01/2022
2	CeruletideIBA 01/2022 - 01/2017
2	Insulin (Novolin)FDA Link 12/2021 - 01/2019
2	Atrial Natriuretic Factor (ANF)IBA 01/2021 - 01/2018
2	Cystatin CIBA 11/2020 - 01/2019
2	Gemcitabine FDA Link 01/2020 - 01/2019
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020 - 01/2017
2	Carbolines (Beta-Carbolines)IBA 01/2020 - 01/2017
2	BerberineIBA 01/2020 - 01/2019
2	Xylenes (Xylene)IBA 01/2020 - 09/2017
2	CytokinesIBA 10/2019 - 12/2014
2	dimethyl 2,2'- ((2,2'- (ethane- 1,1- diyl)bis(1H- indole- 3,2- diyl))diacetateIBA 08/2018 - 01/2018
2	cobaltous chloride (cobalt(II)chloride)IBA 08/2018 - 08/2017
2	urotensin IIIBA 01/2018 - 06/2015
2	imidazo(1,2-a)quinoxaline-2-carboxylic acidIBA 01/2018 - 02/2017
2	Peptides (Polypeptides)IBA 01/2018 - 06/2015
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2018 - 09/2017
2	Carboxylic AcidsIBA 09/2017 - 01/2017
2	PyransIBA 09/2017 - 01/2017
2	Oxygen (Dioxygen)IBA 05/2017 - 01/2013
2	Chemokine ReceptorsIBA 01/2016 - 02/2015
2	LY3009120IBA 09/2015 - 05/2015
2	VemurafenibIBA 05/2015 - 08/2012
2	PlatinumIBA 05/2012 - 12/2011
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 05/2012 - 12/2011
2	Amino Acids FDA Link 05/2012 - 01/2011
2	Adenosine Diphosphate (ADP)IBA 11/2011 - 01/2011
1	ElectrolytesIBA 12/2022
1	KinesinsIBA 08/2022
1	phenolic acidIBA 06/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 06/2022

Therapy/Procedure

10	Therapeutics 06/2022 - 09/2017
5	Drug Therapy (Chemotherapy) 01/2022 - 10/2010
2	Nanospheres 08/2022 - 11/2020
2	Lasers (Laser) 12/2021 - 02/2020
2	Immunotherapy 01/2021 - 12/2017
2	Subcutaneous Injections 01/2017 - 12/2014
1	Length of Stay 12/2022